Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Cancer-associated fibroblasts suppress SOX2-induced dysplasia in a lung squamous cancer coculture.

Chen S, Giannakou A, Wyman S, Gruzas J, Golas J, Zhong W, Loreth C, Sridharan L, Yamin TT, Damelin M, Geles KG.

Proc Natl Acad Sci U S A. 2018 Dec 11;115(50):E11671-E11680. doi: 10.1073/pnas.1803718115. Epub 2018 Nov 28.

2.

Red Cell Distribution Width Predicts 90 Day Mortality in Continuous-Flow Left Ventricular Assist Device Patients.

Truby LK, Sridharan L, Flores RJ, Garan AR, Jennings D, Yuzefpolskaya M, Takeda K, Takayama H, Naka Y, Colombo PC, Topkara VK.

ASAIO J. 2019 Mar/Apr;65(3):233-240. doi: 10.1097/MAT.0000000000000803.

PMID:
29734258
3.

Mechanical Circulatory Support Device Utilization and Heart Transplant Waitlist Outcomes in Patients With Restrictive and Hypertrophic Cardiomyopathy.

Sridharan L, Wayda B, Truby LK, Latif F, Restaino S, Takeda K, Takayama H, Naka Y, Colombo PC, Maurer M, Farr MA, Topkara VK.

Circ Heart Fail. 2018 Mar;11(3):e004665. doi: 10.1161/CIRCHEARTFAILURE.117.004665.

4.

The Utility of Ambulatory Blood Pressure Monitoring for Diagnosing White Coat Hypertension in Older Adults.

Reynolds K, Bowling CB, Sim JJ, Sridharan L, Harrison TN, Shimbo D.

Curr Hypertens Rep. 2015 Nov;17(11):86. doi: 10.1007/s11906-015-0599-0. Review.

5.

Prognostic factors in patients hospitalized for heart failure.

Sridharan L, Klein L.

Curr Heart Fail Rep. 2013 Dec;10(4):380-6. doi: 10.1007/s11897-013-0162-8. Review.

6.

Intervention strategies to reduce the burden of non-communicable diseases in Mexico: cost effectiveness analysis.

Salomon JA, Carvalho N, Gutiérrez-Delgado C, Orozco R, Mancuso A, Hogan DR, Lee D, Murakami Y, Sridharan L, Medina-Mora ME, González-Pier E.

BMJ. 2012 Mar 2;344:e355. doi: 10.1136/bmj.e355.

7.

Injury and health among children in vulnerable families.

Sridharan L, Crandall M.

J Trauma. 2011 Jun;70(6):1539-45. doi: 10.1097/TA.0b013e3182190b94.

PMID:
21817990
8.

Delineation of a cellular hierarchy in lung cancer reveals an oncofetal antigen expressed on tumor-initiating cells.

Damelin M, Geles KG, Follettie MT, Yuan P, Baxter M, Golas J, DiJoseph JF, Karnoub M, Huang S, Diesl V, Behrens C, Choe SE, Rios C, Gruzas J, Sridharan L, Dougher M, Kunz A, Hamann PR, Evans D, Armellino D, Khandke K, Marquette K, Tchistiakova L, Boghaert ER, Abraham RT, Wistuba II, Zhou BB.

Cancer Res. 2011 Jun 15;71(12):4236-46. doi: 10.1158/0008-5472.CAN-10-3919. Epub 2011 May 3.

9.

Depression and thoughts of death among disadvantaged mothers: risk factors and impact on maternal and child health.

Crandall M, Sridharan L, Schermer C.

Arch Suicide Res. 2010;14(3):248-60. doi: 10.1080/13811118.2010.494143.

PMID:
20658378
10.

Injury and health among toddlers in vulnerable families.

Crandall M, Sridharan L, Schermer C.

J Trauma. 2010 May;68(5):1128-33. doi: 10.1097/TA.0b013e3181d89403.

PMID:
20453768
11.

Editorial policies and publication bias: the importance of negative studies.

Sridharan L, Greenland P.

Arch Intern Med. 2009 Jun 8;169(11):1022-3. doi: 10.1001/archinternmed.2009.100. No abstract available.

PMID:
19506169
12.

The oncofetal protein, 5T4, is a suitable target for antibody-guided anti-cancer chemotherapy with calicheamicin.

Boghaert ER, Sridharan L, Khandke KM, Armellino D, Ryan MG, Myers K, Harrop R, Kunz A, Hamann PR, Marquette K, Dougher M, DiJoseph JF, Damle NK.

Int J Oncol. 2008 Jan;32(1):221-34.

PMID:
18097562
13.

Determination of pharmacokinetic values of calicheamicin-antibody conjugates in mice by plasmon resonance analysis of small (5 microl) blood samples.

Boghaert ER, Khandke KM, Sridharan L, Dougher M, DiJoseph JF, Kunz A, Hamann PR, Moran J, Chaudhary I, Damle NK.

Cancer Chemother Pharmacol. 2008 May;61(6):1027-35. Epub 2007 Aug 1.

PMID:
17668210
14.

Tumoricidal effect of calicheamicin immuno-conjugates using a passive targeting strategy.

Boghaert ER, Khandke K, Sridharan L, Armellino D, Dougher M, Dijoseph JF, Kunz A, Hamann PR, Sridharan A, Jones S, Discafani C, Damle NK.

Int J Oncol. 2006 Mar;28(3):675-84.

PMID:
16465373
15.

SKI-606, a Src/Abl inhibitor with in vivo activity in colon tumor xenograft models.

Golas JM, Lucas J, Etienne C, Golas J, Discafani C, Sridharan L, Boghaert E, Arndt K, Ye F, Boschelli DH, Li F, Titsch C, Huselton C, Chaudhary I, Boschelli F.

Cancer Res. 2005 Jun 15;65(12):5358-64.

16.

Antibody-targeted chemotherapy with the calicheamicin conjugate hu3S193-N-acetyl gamma calicheamicin dimethyl hydrazide targets Lewisy and eliminates Lewisy-positive human carcinoma cells and xenografts.

Boghaert ER, Sridharan L, Armellino DC, Khandke KM, DiJoseph JF, Kunz A, Dougher MM, Jiang F, Kalyandrug LB, Hamann PR, Frost P, Damle NK.

Clin Cancer Res. 2004 Jul 1;10(13):4538-49.

17.

Antibody-targeted chemotherapy with CMC-544: a CD22-targeted immunoconjugate of calicheamicin for the treatment of B-lymphoid malignancies.

DiJoseph JF, Armellino DC, Boghaert ER, Khandke K, Dougher MM, Sridharan L, Kunz A, Hamann PR, Gorovits B, Udata C, Moran JK, Popplewell AG, Stephens S, Frost P, Damle NK.

Blood. 2004 Mar 1;103(5):1807-14. Epub 2003 Nov 13.

PMID:
14615373
18.

Characterization of a soluble vascular endothelial growth factor receptor-immunoglobulin chimera.

Kaplan JB, Sridharan L, Zaccardi JA, Dougher-Vermazen M, Terman BI.

Growth Factors. 1997;14(4):243-56.

PMID:
9386989
19.

Flavins inhibit human cytomegalovirus UL80 protease via disulfide bond formation.

Baum EZ, Ding WD, Siegel MM, Hulmes J, Bebernitz GA, Sridharan L, Tabei K, Krishnamurthy G, Carofiglio T, Groves JT, Bloom JD, DiGrandi M, Bradley M, Ellestad G, Seddon AP, Gluzman Y.

Biochemistry. 1996 May 7;35(18):5847-55.

PMID:
8639546
20.

Inhibition of human cytomegalovirus UL80 protease by specific intramolecular disulfide bond formation.

Baum EZ, Siegel MM, Bebernitz GA, Hulmes JD, Sridharan L, Sun L, Tabei K, Johnston SH, Wildey MJ, Nygaard J, Jones TR, Gluzman Y.

Biochemistry. 1996 May 7;35(18):5838-46.

PMID:
8639545

Supplemental Content

Loading ...
Support Center